These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35515016)

  • 41. The diagnostic value of pleural effusion/serum ratio of carcinoembryonic antigen and pleural effusion/serum ratio of interferon-γ in classification of pleural effusion.
    Liang SH; Li C; Xie S
    Lab Med; 2024 Jul; ():. PubMed ID: 39005192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
    Huang WW; Tsao SM; Lai CL; Su CC; Tseng CE
    Pathology; 2010 Apr; 42(3):224-8. PubMed ID: 20350214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.
    Xu CH; Zhan P; Yu LK; Zhang XW
    Tumour Biol; 2014 Feb; 35(2):1599-603. PubMed ID: 24072496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review.
    Tozzoli R; Basso SM; D'Aurizio F; Metus P; Lumachi F
    Clin Biochem; 2016 Nov; 49(16-17):1227-1231. PubMed ID: 27521620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
    Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
    Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Integrated Clinical and Computerized Tomography-Based Radiomic Feature Model to Separate Benign from Malignant Pleural Effusion.
    Cai F; Cheng L; Liao X; Xie Y; Wang W; Zhang H; Lu J; Chen R; Chen C; Zhou X; Mo X; Hu G; Huang L
    Respiration; 2024; 103(7):406-416. PubMed ID: 38422997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
    Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
    Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram.
    Wu A; Liang Z; Yuan S; Wang S; Peng W; Mo Y; Yang J; Liu Y
    Front Oncol; 2021; 11():775079. PubMed ID: 34950585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
    Lee JH; Chang JH
    Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.
    Shin YM; Yun J; Lee OJ; Han HS; Lim SN; An JY; Lee KH; Lee KM; Choe KH
    Cancer Res Treat; 2014 Apr; 46(2):178-85. PubMed ID: 24851110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis.
    Nguyen AH; Miller EJ; Wichman CS; Berim IG; Agrawal DK
    Transl Res; 2015 Nov; 166(5):432-9. PubMed ID: 25953662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Novel Combination of Calprotectin and CXCL12 for Predicting Malignancy in Patients with Exudative Pleural Effusion.
    Luo J; Wang M; Li C; Liang B; Liu D; Shi C; Jiang F; Wang T; Li P; Liang Z
    Medicine (Baltimore); 2015 Nov; 94(47):e2105. PubMed ID: 26632726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
    Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R
    Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pleural fluid carbohydrate antigen 72-4 and malignant pleural effusion: a diagnostic test accuracy study.
    Cao XS; Yan L; Jiang TW; Huang JH; Chen H; Porcel JM; Zheng WQ; Hu ZD
    Ther Adv Respir Dis; 2024; 18():17534666231222333. PubMed ID: 38189269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
    Choi H; Ko Y; Lee CY
    BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review.
    Zhang M; Yan L; Lippi G; Hu ZD
    Transl Lung Cancer Res; 2021 Mar; 10(3):1557-1570. PubMed ID: 33889529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of long noncoding RNA
    Wang WW; Zhou XL; Song YJ; Yu CH; Zhu WG; Tong YS
    Onco Targets Ther; 2018; 11():2333-2344. PubMed ID: 29731641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion.
    Basso SMM; Del Conte A; Zuccon U; Sulfaro SC; Fanti G; Maffeis F; Ubiali P; Ermani M; Lumachi F
    Anticancer Res; 2020 Oct; 40(10):5877-5881. PubMed ID: 32988918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.
    Gu P; Huang G; Chen Y; Zhu C; Yuan J; Sheng S
    J Clin Lab Anal; 2007; 21(6):398-405. PubMed ID: 18022924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
    Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
    Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.